Pharma's Almanac: Nice Insight's Content Community

IDT Biologika

IDT Biologika

Vaccine and Cell & Gene Therapies

Expanding Manufacturing Capacity to Meet Market Demand for Vaccines and Cell and Gene Therapeutics

lrike Fiedler Dr. Rer. Nat.

IDT Biologika

Viral Vectors

Smart Scale-Up: Expanding Viral Vectors With Microcarrier Bead Technology

Heidi Trusheim, Ph.D.

IDT Biologika

Oncolytic Viruses

Best Practices For Oncolytic Virus Design, Development, and Manufacturing

Heidi Trusheim, Ph.D.; Trevor Broadt

IDT Biologika

Scale-Up Collaboration

IDT Biologika Collaborates with Exothera to Push Forward the Scale-Up of Viral Vaccines

IDT Biologika

Vaccines

100 Years in Vaccines and Looking Toward the Future

IDT Biologika

Vaccines

IDT Biologika is Increasing its Production Capacity of Vaccines – Saxony-Anhalt's Prime Minister Reiner Haseloff Visited the New Facilities

IDT Biologika

2021 Roundup: The Year of Cell and Gene Therapy

David Alvaro, Ph.D.

Pharma's Almanac

Collaboration

Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2001

IDT Biologika

Viral Vaccines

Viral Vectors, Vaccines — A New Era Of Collaborative Design

Andreas Neubert, Ph.D.

IDT Biologika

Vaccines

IDT Biologika Celebrates 100 Years of Successful Vaccine Development and U.S. Expansion

Ashik Pavagadhi

IDT Biologika

Vaccine and Cell & Gene Therapies

Expanding Manufacturing Capacity to Meet Market Demand for Vaccines and Cell and Gene Therapeutics

lrike Fiedler Dr. Rer. Nat.

IDT Biologika

Viral Vectors

Smart Scale-Up: Expanding Viral Vectors With Microcarrier Bead Technology

Heidi Trusheim, Ph.D.

IDT Biologika

Oncolytic Viruses

Best Practices For Oncolytic Virus Design, Development, and Manufacturing

Heidi Trusheim, Ph.D.; Trevor Broadt

IDT Biologika

Scale-Up Collaboration

IDT Biologika Collaborates with Exothera to Push Forward the Scale-Up of Viral Vaccines

IDT Biologika

Vaccines

100 Years in Vaccines and Looking Toward the Future

IDT Biologika

Vaccines

IDT Biologika is Increasing its Production Capacity of Vaccines – Saxony-Anhalt's Prime Minister Reiner Haseloff Visited the New Facilities

IDT Biologika

2021 Roundup: The Year of Cell and Gene Therapy

David Alvaro, Ph.D.

Pharma's Almanac

Collaboration

Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2001

IDT Biologika

Viral Vaccines

Viral Vectors, Vaccines — A New Era Of Collaborative Design

Andreas Neubert, Ph.D.

IDT Biologika

Vaccines

IDT Biologika Celebrates 100 Years of Successful Vaccine Development and U.S. Expansion

Ashik Pavagadhi

IDT Biologika